External CD30 antigen stimulation by soluble recombinant CD30 ligand seems to have a counteractivity on cell survival since the growth of human T-cell lymphoma cell lines in vitro is inhibited by apoptosis (32, 33). Here, TNFRSF8 is linked to T-cell non-Hodgkin lymphoma.